mental

Page 2 of 212

Canadian cardiologists.

‘We tested 14 of the 18 patients who were place back on herceptin and they were all able to complete the treatment,’ Dr. McDonald told the conference. The million dollar question is: does herceptin cause long lasting damage to the heart? With the development of newer cancer medicines that act in an identical fashion to herceptin, understanding the effect of this therapy upon the cardiovascular response and system to intervention is definitely critically important. ‘It needs cross-specialty teamwork but coping with herceptin-related cardiac problems is a challenge that can be fulfilled,’ says Dr. McDonald. Stroke and Center Foundation spokesperson Dr. Beth Abramson agrees: ‘That is very good news for Canadian women,’ she says. Continue reading

Page 2 of 212